Comparison

ABBOTT LABORATORIES (ABT) vs Medtronic plc (MDT)

The same filed metrics for both companies, side by side.

What each names as a risk in its own annual report, how each is priced against its own history, and the tracked managers whose latest 13F reports a position in both.

Financials

ABT

ABBOTT LABORATORIES

Medical Devices

Revenue, FY25: $44.33B
Net income: $6.52B
Operating cash flow: $9.57B
Free cash flow: $7.4B
Net margin: 14.72%
Operating margin: 18.17%
Gross margin: 56.42%

MDT

Medtronic plc

Medical Devices

Revenue, FY26: $36.36B
Net income: $4.8B
Operating cash flow: $7.33B
Free cash flow: $5.43B
Net margin: 13.20%
Operating margin: 17.78%
Gross margin: 65.02%

Head-to-head

Filed growth, quality and valuation, read against each company’s own history rather than against the other side.

Metric	ABT	MDT
Revenue growth, latest filed year	+5.67%	+8.43%
Piotroski F-score	6 of 9	7 of 9
P/E against its own history	15.41% below	19.85% below

What each says it is exposed to

From Item 1A of each company’s most recent 10-K.

ABT

Currency moves
Cybersecurity
Product recalls
FDA approval
Litigation
Supply chain

And 15 more.

MDT

Litigation
Reimbursement
Export controls
FDA approval
Currency moves
Product recalls

And 22 more.

Tracked managers holding both

Dodge & Cox Dodge & Cox 0.00% · 0.32%
Joel Greenblatt Gotham Asset Management 0.10% · 0.13%

Updated Sep 17, 2026 · the newer of the two companies' filings